|
|
Volumn 106, Issue 14, 2002, Pages 1750-1752
|
|
Heart transplant: What to expect
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
IMMUNOSUPPRESSIVE AGENT;
ANGIOCARDIOGRAPHY;
ARTICLE;
DIABETES MELLITUS;
GRAFT INFECTION;
GRAFT REJECTION;
HEART FAILURE;
HEART FUNCTION;
HEART GRAFT;
HEART REHABILITATION;
HUMAN;
HYPERTENSION;
LABORATORY TEST;
LYMPHOMA;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RASH;
SKIN CANCER;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
DRUG INTERACTION;
EDUCATION;
HEART DISEASE;
HEART TRANSPLANTATION;
HOSPITAL ADMISSION;
PATIENT EDUCATION;
PREOPERATIVE CARE;
TIME;
TRANSPLANTATION;
DRUG INTERACTIONS;
GRAFT REJECTION;
HEART DISEASES;
HEART TRANSPLANTATION;
HUMANS;
PREOPERATIVE CARE;
TIME FACTORS;
TISSUE AND ORGAN PROCUREMENT;
WAITING LISTS;
|
|
EID: 0036787701
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000031169.85931.4D Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
